.

follow-on-google-news

Shares of Repro India shot up on Monday’s early trades and hit the 20% upper circuit on the back of robust Q4 results. Its shares were locked at ₹ 499.30 apiece on the National Stock Exchange (NSE). 

Ace investor Ashish Kacholia holds 4,60,528 shares or a 3.62% stake in the company. His holdings are worth more than ₹ 22.99 crores as of Monday. As per the shareholding pattern of the December quarter, he held 4,57,962 shares or a 3.60% stake, indicating that his shareholding in the company has increased. 

Repro India provides print solutions which include value engineering, creative designing, pre-press, printing, knitting and assembly and other services across the printing value chain. 

The company recently announced its results for the quarter and the year ended on March 31, 2023. It posted a total income of ₹ 121.50 crores in the January to March quarter (Q4FY23), up 28.71% as compared to 94.40 crores in the corresponding quarter last year (Q4FY22). Its profit came in at ₹ 49.9 crores in Q4FY23, as compared to a loss of 5.58 crores in Q4FY22.

For the entire year (FY23), it posted a total income of ₹ 422.92 crores, up 46.60% as compared to ₹ 288.48 posted in the previous year (FY22). It reported a net profit of ₹ 8.73 crores in FY23, against a loss of ₹ 23.19 crores in FY22.

Repro India is a micro-cap company with a market capitalization of ₹ 551 crores. It has a negative return on equity of 8.88%. However, it has an ideal debt-to-equity ratio of 0.39. Its promoters hold a 51.42% stake in it followed by retail investors with 36.04% and foreign institutions with 12.54%. 

Written by Simran Bafna 

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

×